Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828574) titled 'Pudendal Nerve Block With Articaine and Triamcinolone for Pudendal Neuralgia' on Sept. 15.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).

Primary Sponsor: Irkutsk State Medical University

Condition: Pudendal Neuralgia Pudendal Nerve Entrapment Chronic Pelvic Pain

Intervention: Drug: Articaine and triamcinolone

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: January 15, 2025

Target Sample Size: 120

Countries of Recruitment: Russi...